There has been an error retrieving the data. Please try again.
  • Image attributed to: istock image

    Post-prostatectomy PSA test to determine disease risk

    Early prostate-specific antigen (PSA) measurements following radical prostatectomy should aid risk stratification in men with positive surgical margins, and patients not likely to experience subsequent disease progression can be spared the toxicity of immediate adjuvant radiotherapy and thus, overtreatment.

    BMC Urology 2014, 14:79
  • Image attributed to: istock image

    Reviewing mCRPC management

    Eva Gupta et al. review metastatic Castration Resistant Prostate Cancer (mCRPC) and the rationale for the newly approved hormonal treatments, and discusses ongoing trials that are being done to improve the efficacy of the approved agents for mCRPC.

    BMC Urology 2014, 14:55
  • Image attributed to: istock image

    Supplementing the treatment for CBP

    Broad band, short-lasting antibiotic therapy in association with a nutritional supplement (serenoa repens, lactobacillus sporogens and arbutin) show better control and recurrence rate on patients affected by chronic bacterial prostatitits (CBP) in comparison with antibiotic treatment alone.

    BMC Urology 2014, 14:53
  • Image attributed to: Flickr

    IIEF-5 higher in psychogenic ED

    The International Index of Erectile Function (IIEF-5) may not represent a distinctive diagnostic tool to discriminate pathophysiological differences of ED, with higher IIEF-5 scores in men with pyschogenic related ED and no changes observed amongst men with different organic pathophysiologies.

    BMC Urology 2014, 14:52
Submit a manuscript Sign up for article alerts Contact us

Email updates

Receive periodic news and updates relating to BioMed Central .